TABLE 4.

Predictors of “Cannabis Use” and Reported “Cannabis Benefit” From Survey Cohort Characteristics (Univariate Analysis)

Predictor		OR	95% CI	P*	Predictor Type
Cannabis Use
Sex	Male	1.77	1.27–2.47	0.0007	+
	Female	0.58	0.42–0.81	0.001	−
Ethnicity	Caucasian/European descent	1.89	1.06–3.36	0.030	+
Highest education level	Trade/vocational	1.55	1.12–2.14	0.008	+
	University degree	0.67	0.48–0.94	0.020	−
Tobacco use	Past smoker	1.56	1.08–2.25	0.018	+
	Present smoker	2.49	1.62–3.83	<0.0001	+
	Non smoker	0.44	0.32–0.62	<0.0001	−
IBD diagnosis	Ulcerative colitis	0.59	0.41–0.85	0.004	−
	Crohn’s disease	1.36	0.97–1.90	0.071	ns
	IBD unspecified	2.19	1.1–4.33	0.024	+
Hospitalizations for IBD	Hospitalized	1.61	1.09–2.37	0.018	+
	Never hospitalized	0.62	0.42–0.92	0.018	−
	1–3 times in lifetime	0.54	0.38–0.78	0.001	−
	>10 times in lifetime	1.72	1.14–2.59	0.010	+
Clinical care (IBD specific)	No pharmaceutical regimen	2.09	1.4–3.12	0.0003	+
	Current pharmaceutical regimen	0.48	0.32–0.72	0.0003	−
	No specialist care	2.46	1.53–3.97	0.0002	+
	Under specialist care	0.41	0.25–0.65	0.0002	−
Complementary/alternative therapies	No use of any alternative therapies	0.11	0.05–0.22	<0.0001	−
Cannabis Benefit
Highest education level	University degree	0.16	0.04–0.66	0.011	−
Cannabis use status	Previous	0.21	0.05–0.83	0.026	−
	Current	4.75	1.2–18.7	0.026	+
Complementary/alternative therapies	Chiropractic/osteopathy/massage	0.25	0.07–0.88	0.032	−
	Restriction/exclusion dieting	0.25	0.06–0.97	0.044	−
Type of cannabis used	CBD-only product	0.01	0.008–0.35	0.008	−

Only predictors that were significant (P < 0.05) were reported from the dataset of survey items.

*P-values calculated using a χ ² test for independence.

OR, odds ratio; CI, confidence interval; ns, not significant.